Patent: 10,232,051
✉ Email this page to a colleague
Summary for Patent: 10,232,051
Title: | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule |
Abstract: | Cell binding agent-drug conjugates comprising bridge linkers, and methods of using such linkers and conjugates are provided. |
Inventor(s): | Zhao; Robert Yongxin (Lexington, MA) |
Assignee: | HANGZHOU DAC BIOTECH CO., LTD. (Hangzhou, CN) |
Application Number: | 15/448,639 |
Patent Claims: | see list of patent claims |
Details for Patent 10,232,051
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2035-07-15 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2035-07-15 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2035-07-15 |
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 02/12/2004 | ⤷ Try a Trial | 2035-07-15 |
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 03/28/2007 | ⤷ Try a Trial | 2035-07-15 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |